Protagenic Therapeutics, Inc.\new
PTIX· OTC
PTIXProtagenic Therapeutics, Inc.\new
Filed May 15, 2017 · 10-Q · 45 days after period end · 0001437749-17-009213
| Metric | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Net Income | -$657.85K | -$739.79K | -$37.79K |
| EPS Diluted | -$0.06 | -$52.83 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protagenic Therapeutics, Inc.\new · CIK 1022899 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 15, 2017 · 45 d after period end
